Habib Rahbar, M.D.

Associate Professor
Clinical Director of Breast Imaging, Seattle Cancer Care Alliance
Breast Imaging

Biography

Dr. Rahbar is an associate professor in the University of Washington (UW) Department of Radiology. A board certified radiologist, he works in the breast imaging section at the Seattle Cancer Care Alliance (SCCA) and serves as the Breast Imaging Clinical Director and Fellowship Director. Dr. Rahbar earned his bachelor’s degree from the University of Pennsylvania in Philadelpha and his M.D. from the University of Michigan in Ann Arbor. He completed his radiology residency training and breast imaging fellowship at the UW and stayed on as faculty upon graduation. His clinical practice at the SCCA includes digital mammography, digital breast tomosynthesis (or “3D mammography”), breast ultrasound, breast MRI, and image-guided procedures of the breast. Dr. Rahbar’s primary research interests include the identification of MRI features that can be used to improve management of ductal carcinoma in situ, the use of non-contrast MRI techniques to identify and characterize breast cancers, and the identification of MRI markers of risk of developing breast cancer.

Recent Publications

See all publications on Scopus

Double reading of automated breast ultrasound with digital mammography or digital breast tomosynthesis for breast cancer screening
Lee J., Partridge S., Liao G., Hippe D., Kim A., Lee C., Rahbar H., Scheel J., Lehman C.
Clinical Imaging. 2019 May:119-125

Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702)
Rahbar H., Zhang Z., Chenevert T., Romanoff J., Kitsch A., Hanna L., Harvey S., Moy L., DeMartini W., Dogan B., Yang W., Wang L., Joe B., Oh K., Neal C., McDonald E., Schnall M., Lehman C., Comstock C., Partridge S.
Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Mar:1756-1765

The Impact of Preoperative Breast MRI on Surgical Management of Women with Newly Diagnosed Ductal Carcinoma In Situ
Lam D., Smith J., Partridge S., Kim A., Javid S., Hippe D., Lehman C., Lee J., Rahbar H.
Academic Radiology. 2019 Jan

Association of Magnetic Resonance Imaging and a 12-Gene Expression Assay with Breast Ductal Carcinoma in Situ Treatment
Lehman C., Gatsonis C., Romanoff J., Khan S., Carlos R., Solin L., Badve S., McCaskill-Stevens W., Corsetti R., Rahbar H., Spell D., Blankstein K., Han L., Sabol J., Bumberry J., Gareen I., Snyder B., Wagner L., Miller K., Sparano J., Comstock C.
JAMA Oncology. 2019 Jan

Assessment of Quantitative Magnetic Resonance Imaging Background Parenchymal Enhancement Parameters to Improve Determination of Individual Breast Cancer Risk
Lam D., Hippe D., Kitsch A., Partridge S., Rahbar H.
Journal of Computer Assisted Tomography. 2019 Jan:85-92

Background parenchymal enhancement on breast MRI: A comprehensive review
Liao G., Bancroft L., Strigel R., Chitalia R., Kontos D., Moy L., Partridge S., Rahbar H.
Journal of Magnetic Resonance Imaging. 2019 Jan

Visibility of mammographically occult breast cancer on diffusion-weighted MRI versus ultrasound
Amornsiripanitch N., Rahbar H., Kitsch A., Lam D., Weitzel B., Partridge S.
Clinical Imaging. 2018 May:37-43

Management of high-risk breast lesions found on mammogram or ultrasound: the value of contrast-enhanced MRI to exclude malignancy
Hammersley J., Partridge S., Blitzer G., Deitch S., Rahbar H.
Clinical Imaging. 2018 May:174-180

Advances in Breast MRI in the Setting of Ductal Carcinoma In Situ
Amornsiripanitch N., Lam D., Rahbar H.
Seminars in Roentgenology. 2018 Jan

Ductal carcinoma in situ: Quantitative preoperative breast mr imaging features associated with recurrence after treatment
Luo J., Johnston B., Kitsch A., Hippe D., Korde L., Javid S., Lee J., Peacock S., Lehman C., Partridge S., Rahbar H.
Radiology. 2017 Dec:788-797